US Patent Issued to NEXTBIOMEDICAL on June 9 for "Embolization hydrogel having controllable degradation time, and preparation method therefor" (South Korean Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,015, issued on June 9, was assigned to NEXTBIOMEDICAL Co. LTD. (Incheon, South Korea).

"Embolization hydrogel having controllable degradation time, and preparation method therefor" was invented by Don Haeng Lee (Seoul, South Korea), Eun Hye Lee (Incheon, South Korea), Yi Xian Li (Incheon, South Korea), Se Yun Kim (Incheon, South Korea) and Dae Sung Lee (Incheon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to: an amorphous of spherical embolisation hydrogel having a degradation time that can be precisely controlled in blood vessels; and a preparation method therefor."

The patent was filed on April 28, 2022...